Table 2.
Toxicity | Frequency (%) |
---|---|
Abdominal pain or cramping | 2 (6.67) |
Alkaline phosphatase elevation | 1 (3.33) |
Bilirubin elevation | 2 (6.67) |
Thrombocytopenia | 1 (3.33) |
Fatigue | 1 (3.33) |
Dizziness/lightheadedness | 1 (3.33) |
Bloating | 1 (3.33) |
Hyperglycemia | 1 (3.33) |
Hypoglycemia | 5 (16.67) |
Hyponatremia | 1 (3.33) |
Lymphatics | 1 (3.33) |
Ascites | 1 (3.33) |
Transaminitis or Confusion | 4 (13.33) |
Hepatic Encephalopathy | 2 (6.67) |
Seizure(s) | 1 (3.33) |
Small bowel obstruction | 1 (3.33) |
Liver dysfunction/hepatorenal syndrome | 2 (6.67) |
Cord compression | 1 (3.33) |
Speech impairment (eg, dysphasia or aphasia) | 1 (3.33) |